Literature DB >> 27957226

Atrial Fibrillation in Cardiac Sarcoidosis.

Davendra Mehta1, Jonathan M Willner1, Philippe R Akhrass1.   

Abstract

Sarcoidosis is a systemic granulomatous disease that affects the myocardium. Although ventricular arrhythmias are well known manifestations of cardiac involvement, there is increasing evidence that a significant proportion of patients with cardiac sarcoidosis (CS) also have atrial arrhythmias, atrial fibrillation being the most frequent. The incidence and mechanism of atrial fibrillation in CS is not precisely known. The management of atrial fibrillation in patients with CS is currently done according to the general guidelines for management of atrial fibrillation. Evidence is emerging regarding the additional role of immunosuppression for the treatment of atrial arrhythmias in CS. This paper reviews the incidence, possible mechanisms and treatment strategies of atrial fibrillation in patients with CS.

Entities:  

Keywords:  Arrhythmia Control; Atrial Fibrillation; Cardiac Sarcoidosis; Outcomes; Sarcoidosis

Year:  2015        PMID: 27957226      PMCID: PMC5135185          DOI: 10.4022/jafib.1288

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  36 in total

1.  Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.

Authors:  Bruce A Koplan; Kyoko Soejima; Kenneth Baughman; Laurence M Epstein; William G Stevenson
Journal:  Heart Rhythm       Date:  2006-03-30       Impact factor: 6.343

2.  Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua J Solomon; David Sprunger; Kevin K Brown
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 3.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes.

Authors:  Fabio Tavora; Nathaniel Cresswell; Ling Li; Mary Ripple; Carol Solomon; Allen Burke
Journal:  Am J Cardiol       Date:  2009-06-18       Impact factor: 2.778

Review 5.  Atrial fibrillation as the initial clinical manifestation of cardiac sarcoidosis: a case report and review of the literature.

Authors:  Harsh Golwala; Tarek Dernaika
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-01       Impact factor: 2.160

Review 6.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

7.  Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.

Authors:  Dane Jefic; Binjou Joel; Eric Good; Fred Morady; Howard Rosman; Bradley Knight; Frank Bogun
Journal:  Heart Rhythm       Date:  2008-10-30       Impact factor: 6.343

Review 8.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

9.  Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications.

Authors:  Juan F Viles-Gonzalez; Luciano Pastori; Avi Fischer; Juan P Wisnivesky; Martin G Goldman; Davendra Mehta
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

10.  Electrophysiological features of atrial flutter in cardiac sarcoidosis: a report of two cases.

Authors:  Narayanan Namboodiri; Martin K Stiles; Glenn D Young; Prashanthan Sanders
Journal:  Indian Pacing Electrophysiol J       Date:  2012-12-02
View more
  5 in total

Review 1.  Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review.

Authors:  Lynda E Rosenfeld; Mina K Chung; Clifford V Harding; Paolo Spagnolo; Johan Grunewald; Jason Appelbaum; William H Sauer; Daniel A Culver; Jose A Joglar; Ben A Lin; Christine L Jellis; Timm-Michael Dickfeld; Deborah H Kwon; Edward J Miller; Paul C Cremer; Frank Bogun; Jordana Kron; Ashley Bock; Davendra Mehta; Paul Leis; Konstantinos C Siontis; Elizabeth S Kaufman; Thomas Crawford; Peter Zimetbaum; Edwin T Zishiri; Jagmeet P Singh; Kenneth A Ellenbogen; Jonathan Chrispin; Syed Quadri; Logan L Vincent; Kristen K Patton; Steven Kalbfleish; Thomas D Callahan; Francis Murgatroyd; Marc A Judson; David Birnie; David R Okada; Christopher Maulion; Pavan Bhat; Lavanya Bellumkonda; Ron Blankstein; Richard K Cheng; Maryjane A Farr; Jerry D Estep
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-16

2.  Atrial fibrillation as a presenting symptom of Cardiac Sarcoid.

Authors:  Ali Hussain; Alvin C Yiu; Uzoagu A Okonkwo; John-Paul O'shea
Journal:  J Atr Fibrillation       Date:  2021-06-30

Review 3.  Strategies for Managing Arrhythmias in Patients with Cardiac Sarcoidosis.

Authors:  Kent R Nilsson; Venkateshwar Polsani; Thomas F Deering
Journal:  J Innov Card Rhythm Manag       Date:  2019-01-15

4.  Stroke in cardiac sarcoidosis: Need to worry?

Authors:  Muthiah Subramanian; Sachin Yalagudri; Daljeet Saggu; Jugal Kishore; Muralidhar Reddy; Calambur Narasimhan
Journal:  Indian Heart J       Date:  2020-07-29

Review 5.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.